Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quick Listen: Scrip's Five Must-Know Things

Executive Summary

In this week's podcast version of Five Must-Know Things: a look a top executive compensation; BioMarin preps for Roctavian’s EU debut; Argenx eyes launch hat-trick for Vyvgart; is a biopharma M&A wave coming; and J&J’s Gorsky offers leadership lessons.

Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended 1 July 2022, including: a look a top executive compensation; BioMarin Pharmaceutical Inc. preps for Roctavian’s EU debut; argenx N.V. eyes launch hat-trick for Vyvgart; is a biopharma M&A wave coming; and Johnson & Johnson’s Gorsky offers leadership lessons.

This and all our other podcasts are available on the Pharma Intelligence channel on Apple PodcastsGoogle PodcastsSoundCloudTuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.  

Stories mentioned in this episode:

(Also see "Titans Of Pharma 2022: Johnson & Johnson Pays Highest Exec Compensation Again" - Scrip, 28 Jun, 2022.)

(Also see "BioMarin Rolls Up Sleeves To Prepare For Roctavian’s EU Debut" - Scrip, 24 Jun, 2022.)

(Also see "Argenx Eyes Hat-Trick Of Successful Launches For Vyvgart After CHMP Thumbs-Up" - Scrip, 24 Jun, 2022.)

(Also see "Are Market Conditions Setting Up A Biopharma M&A Wave?" - Scrip, 23 Jun, 2022.)

(Also see "J&J’s Gorsky Offers Leadership Lessons As He Gets Set To Advise Apple" - Scrip, 30 Jun, 2022.)

 

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC146658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel